TIMP1 and atherosclerosis: TIMP1 treatment further increased pSTAT3 levels in CD74+, but not in CD74−, proliferating VSMCs (Fig. 8h and Extended Data Fig. 8c), providing in vivo evidence linking this signaling pathway to the initiation of VSMC proliferation in atherosclerosis.